Aktienanalyse zu Surgery Partners Inc (SGRY)SGRYSurgery Partners Inc

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

Surgery Partners Inc is a good buy right now due to its current price of $14.61, which is significantly below the median analyst price target of $19, indicating a potential upside of 35.9%. Additionally, the stock has shown positive momentum with a 5-day change of +5.18% and a Relative Strength Index (RSI) of 63.79, suggesting it is gaining strength. However, investors should be cautious of the company's substantial debt of $4 billion, which poses a risk to its financial stability.

9 analysts cover SGRY: 4 rate it Buy, 4 Hold and 1 Sell. The average price target is 26.30.